
201 - 500 employees
Founded 1989
🏥 Healthcare
🧬 Biotechnology
⚕️ Healthcare Insurance
💰 $74.8M Post-IPO Equity on 2018-06
Healthcare • Biotechnology • Healthcare Insurance
Vericel Corporation is a biotechnology company that manufactures and markets advanced cell therapy products aimed at the sports medicine and severe burn care markets in the United States. It offers unique treatments such as MACI for knee cartilage repair and Epicel for burn care, and holds exclusive rights to the biological product NexoBrid for eschar removal of severe thermal burns.
🔥 48 minutes ago
Senior MSL advancing Vericel’s regenerative orthopedic cell therapies across the Northeast. Building KOL relationships, supporting clinical evidence generation, and informing Medical Affairs strategy.
🗽 New York, Maryland, +2 more states – Remote
💵 $171k - $195k / year
💰 $74.8M Post-IPO Equity on 2018-06
⏰ Full Time
🟠 Senior
🔥 48 minutes ago
Medical Affairs manager leading Vericel's U.S. Burn Care MSL organization and field strategy. Translating scientific insights into compliant medical initiatives for cell-therapy growth.
🇺🇸 United States – Remote
💵 $185k - $195k / year
💰 $74.8M Post-IPO Equity on 2018-06
⏰ Full Time
🟠 Senior
🔴 Lead
👔 Manager